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ABSTRACT
Taurine (2-aminoethanesulfonic acid) occurs naturally in food, especially in seafood and meat. The aim of our investigation
was to evaluate the effect of dietary taurine on oxidized cholesterol and oxidized fish oil induced toxicity in male Wistar rats.
Thirty male wistar rats were fed with diets supplemented with 5% taurine, 2% oxidized cholesterol or 3% oxidized fish oil for 6
weeks. After feeding such diet, taurine could increase the high density lipoprotein-cholesterol (HDL-C) level in plasma, and glutathione (GSH) level in plasma, and decrease the activities of alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate
transaminase (AST) in plasma, and the levels of low density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-cholesterol (VLDL-C), triglyceride, total cholesterol in plasma, and relative ratios of liver weight to body weight and thiobarbituric
acid-reactive substances (TBARS) level in the rat liver caused by oxidized cholesterol and oxidized fish oil. It could reduce the
biochemical parameters characteristic in the plasma and rate liver caused by oxidized cholesterol and oxidized fish oil. It was also
found that taurine possessed a good recovering effect and a short-term preventing effect from the toxicity of oxidized cholesterol
and oxidized fish oil in rats. The results suggest that taurine may play an important role in suppressing effect by oxidized cholesterol and oxidized fish oil induced toxicity in rats.
Key words: taurine, oxidized cholesterol, hepatotoxicity, oxidized fish oil, rat

INTRODUCTION
Taurine (2-aminoethanesulfonic acid) is a sulfurcontaining amino acid present in high concentrations
in mammalian plasma and cells such as heart, retina,
skeletal muscle, brain, and leukocytes (1). Taurine is a
protective and restorative molecule for the cardiovascular system by alleviating dyslipidemic and atherosclerotic states. It also plays an important role in several
essential biological processes such as development
of the central nervous system and the retina, calcium
modulation, membrane stabilization, reproduction, and
immunity (2-5).
Oxidized cholesterols as well as fatty acid oxidation
in food system have been a concern for human diseases.
A variety of oxidized cholesterols have been detected
in processed foods such as meat products (6), commercial sweet baked foods(7) and sea foods(8). Therefore,
* Author for correspondence. Tel: +886-5-3622-889;
Fax: +886-5-3622-899; E-mail: yhyeh@mail.toko.edu.tw

consumption of oxidized cholesterols is inevitable in
our usual diet. The formation of oxidized cholesterols
was accelerated by PUFAs present in lipids(9). Oxidized
cholesterols have been known to be more injurious to
arterial cells than pure cholesterol and are more directly
connected to the development of atherosclerosis, coronary
heart disease and possibly carcinogenic effects(10-12).
It is well known that n-3 PUFAs and taurine are rich
in marine fish(13,18). We have found that PUFAs inhibited the acute induction of hypertriglyceridemia and liver
enlargement by a single mega dose of retinyl palmitate
in rats (14). On the other hand, these PUFAs are easily
oxidized when fish livers are cooked in the air. The
oxidized fish oil is a hazardous substance to human and
animals (15-17).
Recently, we reported that taurine played an important role in reducing the toxic effect of oxidized fish oil
in rats(18). Marine foods usually contain cholesterol and
PUFAs and produce taurine. When people consume
these kinds of marine foods, the oxidized cholesterol and
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oxidized fish oil were not usually prevented to diets, the
oxidized cholesterol and oxidized fish oil could cause
harm for human health. In addition, taurine plays an
important role in lipid metabolism to produce the bile acid
conjugates in the liver; it can protect the liver against lipid
peroxide. Therefore, the aim of the present study was to
evaluate the effect of taurine on oxidized cholesterol and
oxidized fish oil induced toxicity in male Wistar rats.

MATERIALS AND METHODS
I. Reagents
Taurine was purchased from Dokui Chemical Company (Taiwan), purity of 99.5% to add of 5% in the feed.
II. Preparation of Oxidized Fish Oil
Fish oil was obtained from Kozein Company
(Taiwan), 1 g fish oil contents of 30% (EPA = 180 mg;
DHA = 120 mg; vitamin E = 1 mg). Fish oil was heated
at 60 ± 2°C for 12 hr in a water-bath with air pumping
into it to produce oxidized fish oil(19). The oxidized fish
oil was characterized as follows: POV 302.8 meq/kg oil,
AV 9.13 mg/g oil and TBA 11.63 mg/kg oil. The fresh
fish oil was characterized as follows: POV 14.8 mg/kg oil,
AV 0.35 mg/g oil and TBA 0.24 mg/kg oil.

D = oxidized fish oil + oxidized cholesterol diet (3%
oxidized fish oil + 2% oxidized cholesterol), Group E =
oxidized fish oil + oxidized cholesterol + taurine diet (3%
oxidized fish oil + 2% oxidized cholesterol + 5% taurine).
The composition of the basal and all treatment diets is
listed in Table 1. The concentration of taurine in fish oil
was 5%(22), therefore 5% taurine was added to the treatment diets.
Rats were fasted for 10 hr before the experiment
in the 2, 4 and 6 weeks, respectively. On weeks 2 and
4 blood was obtained by tail vein puncture and the rats
were weighed and euthanized (with diethyl ether) on the
6th week. The blood samples which obtained by heart
puncture with syringes were subjected to RBC count,
Hct, WBC count and Hgb by using a Cell Hematology
Analyzer (DYN 500, Sequoi-Turner, USA). Plasma was
obtained by centrifugation (1,000 x g for 15 min) and
subjected to AST, ALT and ALP activities. Creatinine,
blood urea BUN, HDL-C, cholesterol, triglyceride and
LDL-C+VLDL-C levels in the plasma were determined
by enzymatic assay using commercially available kits
(Merck, Germany).
V. Assays of Enzymatic Activities
The plasma was determined for AST, ALT and ALP
activities by using enzymatic kit with Selectra Analyser
(Merck Co. Ltd, Germany).

III. Preparation of Oxidized Cholesterol

VI. TBARS Production

Cholesterol (99.9% purity, Wako Pure Chemical,
Osaka, Japan) was heated at 150°C for 12 hr to produce
oxidized cholesterol(20). The oxidized cholesterol was
characterized as follows: POV 50.2 meq/kg oil, AV 1.74
mg/g oil, and TBA 1.58 mg/kg oil.

Lipid peroxidation activities in the liver were
assayed by measurement of MDA, an end-product of
peroxidized fatty acids, and TBA reaction product. The
sample of 20% liver homogenate was mixed with 1.0 mL
of 0.4% TBA in 0.2 N HCl and 0.15 mL of 0.2% BHT
in 95% ethanol. The samples were incubated in a 90°C
water-bath for 45 min. After incubation, the TBAMDA
adduct was extracted with isobutanol. The isobutanol
extract was mixed with methanol (2:1) prior to injection
into the system of HPLC. The supernatant was examined
by using the HPLC system at an excitation 515 nm and
an emission 550 nm on a Hitachi Fluorescence Detector
(Japan)(23).

IV. Animals
Male weanling Wistar rats (weight 220 ± 20 g)
were purchased from the National Laboratory Animal
Center. The rats were kept in an air-conditioned room
(23 ± 1°C, 50-60% humidity) lit for 12 hr/day (7 AM
to 7 PM). Experimental protocol was approved by the
Institutional Animal Care and Use Committee of Toko
University. After acclimatizing for 2 wk with a commercial non-purified diet (rodent Laboratory Chow 5001,
Purina Co., USA), rats were randomly assigned to one
of the following five groups (n = 6 per group). A basal
diet (no added cholesterol, oxidized cholesterol, fish oil,
oxidized fish oil, or taurine with a formulation based on
AIN)(21). Group A = received the basal or control diet.
All other groups were fed the basal diet with the addition
of the following: Group B = oxidized fish oil + cholesterol diet (3% oxidized fish oil + 2% cholesterol), Group
C = oxidized fish oil + cholesterol + taurine diet (3%
oxidized fish oil + 2% cholesterol + 5% taurine), Group

VII. GSH Measurement
GSH reacts non-enzymatically with DTNB to yield
GSSG and TNB. GSSG is then reduced enzymatically by
NADPH and GR to regenerate GSH. Concentrations of
DTNB, NADPH and GR are chosen such that the rate of
the overall reaction is linearly proportional to the concentration of total GSH. The rate of formation of TNB is
followed spectrophotometrically, and assay is calibrated using standards. GSH is derivatized if the sample is
reacted with 2-vinylpyridine. Only GSSG is detected
during subsequent assay(24).
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Table 1. Composition of the experimental diet for animal test of taurine, oxidized fish oil and oxidized cholesterol
Dietsa
Ingredient (%)

Control

Oxidized fish oil

Oxidized fish oil

Oxidized fish oil

Oxidized fish oil

+Cholesterol

+Cholesterol +Taurine

+Oxidized cholesterol

+Oxidized cholesterol
+Taurine

Casein

20

20

20

20

20

Methionine

0.3

0.3

0.3

0.3

0.3

Cellulose

10

10

10

10

10

Corn oil

3

0

0

0

0

Oxidized fish oil

0

3

3

3

3

Cholesterol

2

2

2

0

0

Oxidized cholesterol

0

0

0

2

2

Choline

0.2

0.2

0.2

0.2

0.2

AIN mineral

3.5

3.5

3.5

3.5

3.5

AIN vitamin

1

1

1

1

1

Taurine

0

0

5

0

5

Corn starch

25

25

20

25

20

Surcose

35

35

35

35

35

a

Oxidized fish oil + cholesterol: 3% oxidized fish oil and 2% cholesterol in diet; Oxidized fish oil + cholesterol + taurine: 3% oxidized fish
oil and 2% cholesterol and 5% taurine in diet; Oxidized fish oil + oxidized cholesterol: 3% oxidized fish oil and 2% oxidized cholesterol in
diet; Oxidized fish oil + oxidized cholesterol + taurine: 3% oxidized fish oil and 2% oxidized cholesterol and 5% taurine in diet.

VIII. Histopathology
Liver samples were fixed in 10% formalin phosphatebuffer, dehydrated, paraffin-embedded, and archived.
Sections of 2-4 μM of all zones of hepatic lobule and
median part of kidney were sagitally cut and mounted
on aminopropyltriethoxysilane-coated slides (APTS, A3648, Sigma). Following deparaffinization in xylene,
sections were rehydrated, stained with hematoxylin and
eosin (H&E) and examine for light microscopy (25).
IX. Statistical Analysis
Statistical analysis for differences among rats in the
experimental groups was performed by the 2-way analysis of variance procedure and Duncan’s new multiple
range tests(26). A P value < 0.05 was considered statistically significant.

RESULTS
In clinical plasma examination, the indicators
concerning blood characters, liver function and kidney
function have been determined in the toxicity. Activities
of AST, ALT and ALP in plasma are generally tested as
indicators for liver functions, and the levels of creatinine,

plasma urea nitrogen are tested as indicators for kidney
functions (27-29).
The effects of taurine, oxidized cholesterol and
oxidized fish oil in rats after 6 weeks of feeding, and
the effect of RBC, Hgb and Hct on the blood of rats
are shown in Figure 1. The RBC, Hgb and Hct in the 6
weeks of rats fed, group B, group C, group D and group E
were significantly higher than of basal diet (group A) (P
< 0.05), but WBC were not significantly different on the
blood (P > 0.05) (data not shown).
The effects of taurine, oxidized cholesterol and
oxidized fish oil on the relative of liver weight to the
body weight in rats fed diet after 6 weeks are shown in
Figure 2. After 6 weeks of treatment, group B and D
were significantly higher than group A, C, and E on the
relative liver weight, but five groups were not significantly different on the relative kidney weight (P > 0.05) (data
not shown).
The activities of taurine, oxidized cholesterol and
oxidized fish oil on AST, ALT, ALP of rats during 6
weeks of treatment are shown in Figure 3. The activity
of AST in the 4th week of treatment Group B, C, D and
E were significantly higher than basal diet (P < 0.05),
but in the 6th week of treatment Group C and E were not
significantly different than basal diet (P > 0.05). In terms
of the ALT activity in the first 2 weeks, Group B was
significantly higher than the other groups (P < 0.05), but
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Figure 1. Effects of taurine, oxidized fish oil and oxidized cholesterol on the RBC, Hgb and Hct of rats fed diet after 6 groups. a-b: values in
the same week with different superscript are significantly different (P < 0.05). Group A = received the basal or control diet. All other groups
were fed the basal diet with the addition of the following: Group B = oxidized fish oil + cholesterol diet (3% oxidized fish oil + 2% cholesterol),
Group C = oxidized fish oil + cholesterol + taurine diet (3% oxidized fish oil + 2% cholesterol + 5% taurine), Group D = oxidized fish oil +
oxidized cholesterol diet (3% oxidized fish oil + 2% oxidized cholesterol), Group E = oxidized fish oil + oxidized cholesterol + taurine diet (3%
oxidized fish oil + 2% oxidized cholesterol + 5% taurine).

ing that individual component has maximal toxic effects
in rats.
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Liver weight / Body weight (%)

in the first 4 and 6 weeks, Group B and D were significantly higher than Group C, E and A. As for the order
of ALP activity in the first 4 and 6 weeks, Group D was
significantly higher than Group B, E, C and A (P < 0.05).
The effects of taurine, oxidized cholesterol and oxidized
fish oil on the concentration of GSH in the plasma of rats
are shown in Figure 3. After 6 weeks of treatment, Group
A, C and E were significantly higher than Group B and
D (P < 0.05). The effects of BUN and creatinine in the
plasma by rats fed diet for 6 weeks are shown in Figure
3. Throughout the 6-week treatment, the BUN and creatinine in the 2, 4 and 6 weeks were not significantly different (P > 0.05).
The effects of the triglyceride in the plasma by rats
fed diet for 6 weeks are shown in Figure 4. Group B and
D had significantly higher triglyceride than Group A, C
and E in the 2, 4 and 6-week periods (P < 0.05).
The effects of the total cholesterol, HDL-C and LDLC＋VLDL-C in the plasma by rats fed diet for 6 weeks are
shown in Figure 4. In the 2nd, 4th and 6th week, Group
D had the highest total cholesterol effect than group B, E,
C and A (P < 0.05). After 6 weeks of treatment, Group
A was significantly higher than the other groups on the
HDL-C values (P < 0.05). On the total LDL-C +VLDLC, Group D and B were significantly higher than Group
A, C and E (P < 0.05).
The effects of TBARS in the liver of rats fed diet
after 6 weeks are shown in Figure 5. The level of TBARS
in the kidney is not significantly different. In terms of
the TBARS level in the liver in the 6th week, Group D
was significantly higher than the other groups (P < 0.05).
We have not observed the synergetic toxicity of
oxidized fish oil and oxidized cholesterol in rats, suggest-

4

c

c
3

b

b

a

2

1

0

6

Weeks

Figure 2. Effects of t au r i ne, oxidized f ish oil and oxidized
cholesterol on relative liver weight in rats fed diet after 6 groups. a-c:
values in the same week with different superscript are significantly
different (P < 0.05). Group A = received the basal or control diet.
All other groups were fed the basal diet with the addition of the
following: Group B = oxidized fish oil + cholesterol diet (3% oxidized
fish oil + 2% cholesterol), Group C = oxidized fish oil + cholesterol
+ taurine diet (3% oxidized fish oil + 2% cholesterol + 5% taurine),
Group D = oxidized fish oil + oxidized cholesterol diet (3% oxidized
fish oil + 2% oxidized cholesterol), Group E = oxidized fish oil
+ oxidized cholesterol + taurine diet (3% oxidized fish oil + 2%
oxidized cholesterol + 5% taurine).
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Figure 3. Effects of taurine, oxidized fish oil and oxidized cholesterol on the activity of AST, ALT, ALP, BUN, creatinine and concentration
of GSH in the plasma of rats fed diet for 2, 4 and 6 groups. a-d values in the same week with different superscript are significantly different (P
< 0.05). Group A = received the basal or control diet. All other groups were fed the basal diet with the addition of the following: Group B =
oxidized fish oil + cholesterol diet (3% oxidized fish oil + 2% cholesterol), Group C = oxidized fish oil + cholesterol + taurine diet (3% oxidized
fish oil + 2% cholesterol + 5% taurine), Group D = oxidized fish oil + oxidized cholesterol diet (3% oxidized fish oil + 2% oxidized cholesterol),
Group E = oxidized fish oil + oxidized cholesterol + taurine diet (3% oxidized fish oil + 2% oxidized cholesterol + 5% taurine).

6

Weeks

Figure 4. Effects of taurine, oxidized fish oil and oxidized cholesterol on the triglyceride,
total cholesterol, level of HDL-C and level of LDL-C + VLDL-C of plasma in rats fed
diets for 6 weeks. a-e values in the same week with different superscript are significantly
different (P < 0.05). Group A = received the basal or control diet. All other groups
were fed the basal diet with the addition of the following: Group B = oxidized fish oil +
cholesterol diet (3% oxidized fish oil + 2% cholesterol), Group C = oxidized fish oil +
cholesterol + taurine diet (3% oxidized fish oil + 2% cholesterol + 5% taurine), Group
D = oxidized fish oil + oxidized cholesterol diet (3% oxidized fish oil + 2% oxidized
cholesterol), Group E = oxidized fish oil + oxidized cholesterol + taurine diet (3% oxidized
fish oil + 2% oxidized cholesterol + 5% taurine).
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Histopathological changes were assessed by observing liver section for necrotic and swollen hepatocytes.
Referring to the histological lfinding is shown in Figure
6, swollen cells are identified by enlargement and
ruptured plasma membrane. Morphological alterations
involving all zones of hepatic lobule were observed in
the Group B and D treatment revealed necrosis or degen-

Level of TBARS (nmol/g wet liver)

80
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B

C

D

E

60
c
b

40
a

b

a

20

0

6

Weeks

Figure 5. Effects of t au r i ne, oxidized f ish oil and oxidized
cholesterol on the level of TBARS in the liver of rats fed diets after
6 weeks. a-c values in the same week with different superscript
are significantly different (P < 0.05). Group A = received the basal
or control diet. All other groups were fed the basal diet with the
addition of the following: Group B = oxidized fish oil + cholesterol
diet (3% oxidized fish oil + 2% cholesterol), Group C = oxidized fish
oil + cholesterol + taurine diet (3% oxidized fish oil + 2% cholesterol
+ 5% taurine), Group D = oxidized fish oil + oxidized cholesterol diet
(3% oxidized fish oil + 2% oxidized cholesterol), Group E = oxidized
fish oil + oxidized cholesterol + taurine diet (3% oxidized fish oil +
2% oxidized cholesterol + 5% taurine).

eration and enlargement of the tubular or peritubular
tissues.

DISCUSSION
The activities of AST and ALT in the plasma of
rats were significantly elevated by cholesterol, oxidized
fish oil and oxidized cholesterol injury to the liver (30).
Wright et al. pointed out that taurine was presented by
the high content of taurine in cell membrane to preserve
liver cells(31). In this study, the activities of AST, ALT
and ALP in the plasma of rats showed to be significantly affected by oxidized cholesterol and oxidized fish oil.
In the experimental period, the food consumption of
rats significantly decreased in the rats groups fed with
oxidized fish oil diet. The palatability of the diet might
also be affected. Therefore, the oxidized cholesterol and
oxidized fish oil diet may induce liver injury and reduce
diet palatability in rats.
A study suggested taurine may be involved in lipid
metabolism from daily urinary taurine excretion and
serum HDL-C(32). The ratio between HDL-C and LDL-C
＋VLDL-C is known as the atherogenic index. In animals
fed a normal diet, the serum total cholesterol, LDL-C,
triglyceride, and hepatic cholesterol, triglyceride, and
free fatty acid were effectively decreased by taurine (3335)
. HDL-C, the antiatherogenic form of serum cholesterol, was found to be reduced by taurine (34). The significance of these effects has yet to be explained and given
practical and scientific meaning. This study showed that
the total cholesterol or the total LDL-C＋VLDL-C in
the plasma of rats are significantly affected by taurine.
However, the data strongly suggest that taurine modulates serum lipid levels in rats.

Figure 6. Microscopic cross section of liver
lobules in rat after 6 weeks fed diet with (A)
control, (B) oxidized fish oil + cholesterol, (C)
oxidized fish oil + cholesterol + taurine, (D)
oxidized fish oil + oxidized cholesterol and
(E) oxidized fish oil + oxidized cholesterol +
taurine (x 400 H&E). Bar represents 0.01 mm.
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Dietary intake of long chain PUFAs is known to be
associated with a decrease in the incidence of cardiovascular disease (36-39). Fish oils have a high content of
n-3 long-chain PUFAs. The most reproducible effect of
dietary fish oil on serum lipids is a decrease in triglyceride levels (35,40). Fish is also the richest dietary source
of taurine than poultry and beef, which likewise have a
platelet-stabilizing effect (41,42). Although both fish oil and
taurine can lower elevated the blood pressure (30,43-45), the
stroke protection associated with fish ingestion persists
after statistical adjustment for blood pressure. Those not
wishing to eat fish may likely obtain comparable benefit
by taking fish oil and taurine supplements. It is conceivable that the reduction of stroke risk associated with high
protein intakes in Asian epidemiology reflects, in part,
the fact that sulf hydryl amino acids are the biosynthetic
precursors for taurine; moreover, the only dietary sources of pre-formed taurine are flesh foods. Plasma taurine
levels tend to be lower in vegans than in omnivores and
urinary taurine levels are dramatically lower (46).
The TBARS and GSH levels in the liver are additional indicators of liver injury. TBARS is an end-product of lipid peroxidation. The level of TBARS in rat
liver was significantly reduced when the rats were fed
with the supplement of taurine. This result is the same
as that reported previously(47,48). Therefore, it is reasonable to assume that taurine may act as a good scavenger in reducing the production of lipid peroxidation
induced by drugs (49), vitamin A(50) and heavy metal(51).
The level of GSH in rat liver was raised significantly
when the rats were fed with the supplement of taurine.
It means that taurine may play an important role in the
metabolism of GSH, but this related mechanism should
be studied further. On the other hand, taurine can also
function as a regulator of intracellular calcium homeostasis (52) that can be disturbed due to cholesterol,
oxidized fish oil and oxidized cholesterol toxicity (53).
Taurine has been shown to protect against endothelial
cell death by modulating intracellular calcium fluxes (12).
Finally, taurine may ameliorate oxidized cholesterol and
oxidized fish oil induced hepatic injury by enhancing the
activities of endogenous antioxidants. Support for this
concept comes from our results, which show that taurine
produced a remarkable significant increase in hepatic
GSH level. This could be attributed to the role of taurine
in maintaining a normal GSH level(54) and its antioxidant action against lipid peroxidation, thus conserving
the internal antioxidants system. The stimulatory effect
of taurine on endogenous antioxidants was reported by
others (55,56). However, the TBARS and GSH levels in
the liver are additional indicators of liver injury. The
data did not prove the mechanism of oxidized cholesterol
and oxidized fish oil injury by lipid peroxidation but it is
strongly suggestive that it plays an important role. The
level of TBARS in rat plasma and liver was significantly
reduced when the rats were fed diet with the supplement
of taurine (57,58). While it was raise significantly when

the rats were fed diet with the supplement of taurine.
It means that taurine may play an important role in the
metabolism of GSH and in preventing lipid peroxidation
but these related mechanism should be studied further.
Taurine supplementation in our study significantly mitigated oxidized cholesterol and oxidized fish
oil induced oxidative stress and hepatotoxicity. This
was clearly manifested by the improvement in all the
biochemical variables determining oxidized cholesterol hepatotoxicity (Figures 3 and 5). In addition, taurine
inhibited lipid peroxidation, diminished the decrease
in catalase and GSH-Px activities, and abrogated GSH
depletion induced by oxidized cholesterol.
Consistent with our finding, taurine has been
demonstrated to protect against hepatotoxicity induced
by several free radicals generating insults including lipopolysaccharide (59), acetaminophen(60), thioacetamide (61),
and ischemia/reperfusion(62). Moreover, the antioxidant
effect of taurine was shown in other organs including the
lung(63), kidney(64) and heart (65). In addition, other antioxidants have been shown to reduce oxidized cholesterol
induced hepatotoxicity.
Taurine has been demonstrated to function as a direct
antioxidant that scavenges or quenches oxygen free radicals, thus inhibiting lipid peroxidation, and as an indirect antioxidant that prevents the increase in membrane
permeability resulting from oxidant injury in many tissues
including liver(62). Taurine might stimulate s-nitrosylation
of GSH producing s-nitrosoglutathione, which is approximately 100 times more potent than the classical GSH. In
addition, s-nitrosylation of cysteine residues by nitrosoglutathione can inactivate caspase-3, thus preventing hepatic
cell apoptosis(66). Moreover, taurine might lessen oxidized
cholesterol induced oxidative injury either by forming
chloramines, known to be more stable and less reactive
molecules, with hypochlorous (HOCl) and HOCl-metalloproteins, or by binding free metal ions such as Fe2+ to its
sulfonic acid group(67,68).
As an indirect antioxidant, taurine has been proposed
as a membrane stabilizer that can maintain membrane
organization, prevent ion leakage and water influx, and
subsequently, avoid cell swelling(62,65). The stabilizing effect of taurine on cellular membrane has been
suggested to be associated with the interaction between
taurine and polyunsaturated fatty acids in the membrane,
which results in increasing in the affinity of taurine for
its carrier transport and the interaction between taurine
and the sites related to anion transport and water influx.
This property of taurine may also partly account for its
protection against oxidized cholesterol induced hepatocyte necrosis.
On the other hand, taurine can also function as a
regulator of intracellular calcium homeostasis (2) that can
be disturbed by oxidized cholesterol toxicity. Taurine
has been shown to protect against endothelial cell death
by modulating intracellular calcium fluxes (69). Finally,
taurine may ameliorate oxidized cholesterol and oxidized
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fish oil induced hepatic injury by enhancing the activities of endogenous antioxidants. Support for this concept
comes from our results, which show that taurine promoted a remarkable significant increase in hepatic GSH level
and GSH-Px and catalase activities. This could be attributed to the role of taurine in maintaining a normal IGF-I
level(70) and its antioxidant action against lipid peroxidation, thus conserving the internal antioxidants system.
The stimulatory effect of taurine on endogenous antioxidants was reported by others (64,71). Together, the results
of the present study demonstrate that administration of
taurine has a therapeutic role in preventing cyclosporineinduced hepatotoxicity, possibly through its unique cytoprotective properties such as antioxidant activity.
In conclusion, we suggest that: (a) the imbalance
between production of oxygen free radicals and the
endogenous antioxidant defense system, as a result of the
effect of oxidized cholesterol and oxidized fish oil, is the
main mechanism responsible for peroxide accumulation
and hepatotoxicity; and (b) taurine reduces the oxidative stress through the inhibition of lipid peroxidation (a
widely known mechanism).
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